107 related articles for article (PubMed ID: 23774208)
41. BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation.
Palona I; Namba H; Mitsutake N; Starenki D; Podtcheko A; Sedliarou I; Ohtsuru A; Saenko V; Nagayama Y; Umezawa K; Yamashita S
Endocrinology; 2006 Dec; 147(12):5699-707. PubMed ID: 16959844
[TBL] [Abstract][Full Text] [Related]
42. miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα.
Luo M; Ding L; Li Q; Yao H
Breast Cancer; 2017 Sep; 24(5):673-682. PubMed ID: 28138801
[TBL] [Abstract][Full Text] [Related]
43. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
44. CNK1 promotes invasion of cancer cells through NF-kappaB-dependent signaling.
Fritz RD; Radziwill G
Mol Cancer Res; 2010 Mar; 8(3):395-406. PubMed ID: 20197385
[TBL] [Abstract][Full Text] [Related]
45. Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone.
Gordon AH; O'Keefe RJ; Schwarz EM; Rosier RN; Puzas JE
Cancer Res; 2005 Apr; 65(8):3209-17. PubMed ID: 15833852
[TBL] [Abstract][Full Text] [Related]
46. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
[TBL] [Abstract][Full Text] [Related]
47. Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells.
Xie W; Wang Y; Huang Y; Yang H; Wang J; Hu Z
Biochem Biophys Res Commun; 2009 Feb; 379(4):1027-32. PubMed ID: 19141294
[TBL] [Abstract][Full Text] [Related]
48. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
49. Cellular prion protein regulates invasion and migration of breast cancer cells through MMP-9 activity.
Gil M; Kim YK; Kim KE; Kim W; Park CS; Lee KJ
Biochem Biophys Res Commun; 2016 Jan; 470(1):213-219. PubMed ID: 26778001
[TBL] [Abstract][Full Text] [Related]
50. Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers.
Lee ST; Li Z; Wu Z; Aau M; Guan P; Karuturi RK; Liou YC; Yu Q
Mol Cell; 2011 Sep; 43(5):798-810. PubMed ID: 21884980
[TBL] [Abstract][Full Text] [Related]
51. Cis-guggulsterone inhibits the IKK/NF-κB pathway, whereas trans-guggulsterone inhibits MAPK/AP-1 in MCF‑7 breast cancer cells: guggulsterone regulates MMP‑9 expression in an isomer-specific manner.
Noh EM; Chung EY; Youn HJ; Jung SH; Hur H; Lee YR; Kim JS
Int J Mol Med; 2013 Feb; 31(2):393-9. PubMed ID: 23242121
[TBL] [Abstract][Full Text] [Related]
52. DSIF restricts NF-κB signaling by coordinating elongation with mRNA processing of negative feedback genes.
Diamant G; Amir-Zilberstein L; Yamaguchi Y; Handa H; Dikstein R
Cell Rep; 2012 Oct; 2(4):722-31. PubMed ID: 23041311
[TBL] [Abstract][Full Text] [Related]
53. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
54. The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells.
Kang H; Ko J; Jang SW
Biochem Biophys Res Commun; 2012 Jun; 423(1):188-94. PubMed ID: 22640735
[TBL] [Abstract][Full Text] [Related]
55. Transducin β-like protein 1 recruits nuclear factor κB to the target gene promoter for transcriptional activation.
Ramadoss S; Li J; Ding X; Al Hezaimi K; Wang CY
Mol Cell Biol; 2011 Mar; 31(5):924-34. PubMed ID: 21189284
[TBL] [Abstract][Full Text] [Related]
56. EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancer.
Sankpal NV; Fleming TP; Gillanders WE
Mol Cancer Res; 2013 Apr; 11(4):418-26. PubMed ID: 23378578
[TBL] [Abstract][Full Text] [Related]
57. Epithelial-to-mesenchymal transition and NF-kB pathways are promoted by a mutant form of DDB2, unable to bind PCNA, in UV-damaged human cells.
Perucca P; Bassi E; Vetro M; Tricarico A; Prosperi E; Stivala LA; Cazzalini O
BMC Cancer; 2024 May; 24(1):616. PubMed ID: 38773406
[TBL] [Abstract][Full Text] [Related]
58. Damaged DNA binding protein 2 plays a role in breast cancer cell growth.
Kattan Z; Marchal S; Brunner E; Ramacci C; Leroux A; Merlin JL; Domenjoud L; Dauça M; Becuwe P
PLoS One; 2008 Apr; 3(4):e2002. PubMed ID: 18431487
[TBL] [Abstract][Full Text] [Related]
59. Identification of epithelial stromal interaction 1 as a novel effector downstream of Krüppel-like factor 8 in breast cancer invasion and metastasis.
Li T; Lu H; Shen C; Lahiri SK; Wason MS; Mukherjee D; Yu L; Zhao J
Oncogene; 2014 Sep; 33(39):4746-55. PubMed ID: 24096480
[TBL] [Abstract][Full Text] [Related]
60. GATA4 regulates the transcription of MMP9 to suppress the invasion and migration of breast cancer cells via HDAC1-mediated p65 deacetylation.
Yang Y; Song S; Li S; Kang J; Li Y; Zhao N; Ye D; Qin F; Du Y; Sun J; Yu T; Wu H
Cell Death Dis; 2024 Apr; 15(4):289. PubMed ID: 38653973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
